Elbasvir 50mg / Grazoprevir 100mg tablets
NHS hospitals in England used £65,564,723 of indicative cost of Elbasvir 50mg / Grazoprevir 100mg tablets in the 12 months to April 2026, about 0.3% of all hospital medicines spend. That is down 16.3% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Elbasvir 50mg / Grazoprevir 100mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Elbasvir 50mg / Grazoprevir 100mg tablets most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Southend Univ Hosp Nhs Foundation Trust | £12,105,727 |
| Manchester University Nhs Ft | £4,148,797 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £2,469,812 |
| Nottingham University Hospitals Trust | £2,299,480 |
| Aintree University Hospital Nhs Ft | £1,983,149 |
| Barts Health Nhs Trust | £1,618,152 |
| Leeds Teaching Hpls Nhs Trust | £1,472,154 |
| Chelsea & Westminster Hospital Nhs Ft | £1,435,654 |
| Imperial College Healthcare Nhs Trust | £1,240,989 |
| Royal Surrey County Hosp Nhs Found Trust | £1,204,489 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.